Adam Koppel insider trades
Open-market stock purchases and sales by Adam Koppel, Unknown at Kailera Therapeutics, Inc, from SEC Form 4 filings since Mar 7, 2013.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -60%.
Companies traded
- KLRA Kailera Therapeutics, Inc: 1 buy, last Apr 20, 2026
- CERE Cerevel Therapeutics Holdings, Inc: 3 buys, last Aug 1, 2024
- FHTX Foghorn Therapeutics Inc: other filings, last Jun 26, 2024
- SLDB Solid Biosciences Inc: 1 buy, last Jan 11, 2024
- APTX Aptinyx Inc: 2 buys, last May 26, 2022
- DRNA Dicerna Pharmaceuticals Inc: 2 sales, last Dec 28, 2021
- BLSA BCLS Acquisition Corp: other filings, last Oct 26, 2020
- TRVN Trevena Inc: other filings, last May 16, 2018
- PTCT PTC Therapeutics, Inc: 1 buy, last Jan 3, 2017
- BIIB Biogen Inc: 2 sales, last Jun 6, 2016